← Eichor
Condition: Renal Allograft Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Renal Allograft

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Phase 1/Phase 2 · 9 location(s) · Eledon Pharmaceuticals · NCT05027906Concomitant Renal and Urinary Bladder Allograft Transplantation
EARLY_Phase 1 · 2 location(s) · Mayo Clinic · NCT04626167Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01531257Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
Phase N/A · 26 location(s) · University of Alberta · NCT01299168A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-c
Phase N/A · 3 location(s) · Tongji Hospital · NCT07333495SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
Phase 4 · 1 location(s) · Odense University Hospital · NCT07143773Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry
Phase N/A · 4 location(s) · LifeNet Health · NCT05880537Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation
NA · 1 location(s) · King Chulalongkorn Memorial Hospital · NCT03071536Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
NA · 1 location(s) · University of California, Los Angeles · NCT06337942A Two Part Dose-escalation Safety and Efficacy Study of CID-103 in Adults With Active and Chronic Active Renal Allograft
Phase 1/Phase 2 · 4 location(s) · CASI pharmaceuticals, Inc. · NCT07641426Islet Transplantation in Type 1 Diabetic Kidney Allograft
Phase 2 · 1 location(s) · University of Chicago · NCT01241864A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to
Phase 3 · 38 location(s) · Bristol-Myers Squibb · NCT04877288Molecular Landscape of Microvascular Inflammation in Kidney Allografts
Phase N/A · 3 location(s) · Paris Translational Research Center for Organ Transplantatio · NCT06342128Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation
NA · 1 location(s) · Shahid Beheshti University of Medical Sciences · NCT07033858CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Phase 1/Phase 2 · 1 location(s) · AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · NCT07053462Australian Genomics Of Chronic Allograft Dysfunction Study
Phase N/A · 2 location(s) · Western Sydney Local Health District · NCT06314230Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein B
Phase 4 · 1 location(s) · University Hospital, Strasbourg, France · NCT04989491Frailty Among Renal Transplant Recipients and Relation to Chronic Allograft Dysfunction
NA · 1 location(s) · Alexandria University · NCT07181096Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to S
Phase 4 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06676696
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.